TY  - GEN
AU  - Gabriel,Erin E
AU  - Gilbert,Peter B
TI  - Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy
SN  - 1468-4357
PY  - 2014///1210
KW  - Biomarkers
KW  - Diabetes Complications
KW  - prevention & control
KW  - Diabetes Mellitus, Type 1
KW  - drug therapy
KW  - Endpoint Determination
KW  - Humans
KW  - Likelihood Functions
KW  - Models, Statistical
KW  - Randomized Controlled Trials as Topic
KW  - standards
KW  - Research Design
KW  - Risk Assessment
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1093/biostatistics/kxt055
ER  -